‘Diesel price hike to add 120 bps to inflation’

Bank of America-Merrill Lynch (BofA-ML) today said the recent partial diesel price hike will inflict a 1.20 per cent burden on the already sticky inflation and that the price index will remain elevated throughout the next fiscal.

"The bottomline is that inflation will follow an inverted U in FY14, after last week's diesel price hikes that will add 120 bps to FY14 inflation.

"Inflation should persist around 7 per cent in the March quarter, which will then likely go back up to 7.5-8 per cent in H2 of 2013. But it should abate to 6.5-7 per cent by March 2014," BofA-ML India chief economist Indranil Sen Gupta said in a note.

However, the American brokerage said it continues to expect the Reserve Bank to cut policy rates by 25 bps on January 29. It is likely to be cut by 75 bps by June, then pause in the second half as inflation picks up and cut another 50 bps again in the March 2014 quarter as inflation subsides.

The government allowed oil marketing companies to increase the retail price of the fuel by 50 paise per every month and ended subsidy on bulk and institutional diesel consumers like railways, state road transport corporations and to power plants. The current subsidy on diesel stands at Rs 9.50 to a litre.

Gupta said, "We expect inflation to persist at 7-7.5 per cent in the March quarter after the diesel price hike. And accordingly we hike our March 2013 inflation forecast to 7.3 per cent from 7.1 per cent."

On the impact of the staggered diesel price hike, it said the move will add about 120 bps to FY14 inflation if crude remains at $110 per barrel.

However, on the positive side, Gupta said, the price hike will help the government trim its oil subsidy by Rs 20,000 crore to Rs 67,300 crore.

... contd.

ALSO READ

33% Indians feel offering cash to win biz is justified: Survey

MSCI world share index puts stocks worldwide at 5-yr high as data, central banks support

Railway Minister Pawan Kumar Bansal in for more trouble as drug tests at family firm fail

GlaxoSmithKline Pharma Q1 net profit up 37.52%